[1]韩娜,王健,张中冕.培美曲塞联合顺铂治疗晚期非小细胞肺癌18例[J].郑州大学学报(医学版),2010,(05):876-876.
点击复制

培美曲塞联合顺铂治疗晚期非小细胞肺癌18例
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2010年05期
页码:
876-876
栏目:
出版日期:
2010-09-30

文章信息/Info

作者:
韩娜王健张中冕
郑州大学第二附属医院肿瘤科 郑州450014
关键词:
非小细胞肺癌培美曲塞顺铂

参考文献/References:

[1]Calvert H.An overview of folate metabolism:features relevant to the action and toxicities of antifolate anticancer agents[J].Semin Oncol,1999,26(2 Suppl 6):3 [2]程志祥,王科明.肿瘤疗效评价研究进展[J].中国肿瘤,2009,18(78):548
[3]Hanna N,Shepherd FA,Fossella FV,et al.Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non smallcell lung cancer previously treated with chemotherapy[J].J Clin Oncol,2004,22(9):1 589
[4]Monnerat C,Le Chevalier T,Kelly K,et al.Phase Ⅱ study of pemetrexedgemcitabine combination in patients with advancedstage nonsmall cell lung cancer[J].Clin Cancer Res,2004,10(16):5 439
[5]洪丹,张泝平.培美曲塞的实验和临床研究进展[J].中国癌症杂志,2008,18(1):73
[6]Rusthoven JJ,Eisenhauer E,Butts C,et al.Multitargeted antifolate LY23l5l4 as firstline Chemotherapy for patients with advanced nonsmall cell lung cancer:A phase Ⅱ study.National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol,1999,17(4):1 194
[7]Clarke SJ,Abratt R,Goedha1s L,et al.Phase Ⅱ trial of pemetrexed disodium(ALIMTA,LY231514)in chermotherapynaive patients with advanced nonsmallcell lung cancer[J].Ann Oncol,2002,13(5):737
[8]Scagliotti GV.Pemetrexed plus carboplatin or oxaliplatin in advanced nonsmall cell lung cancer[J].Semin Onco1,2005,32(Suppl):S5

相似文献/References:

[1]夏宗江,赵松,崔广晖#.非小细胞肺癌组织中Survivin、Bcl2及PCNA蛋白的表达[J].郑州大学学报(医学版),2010,(02):322.
[2]李甸源,高松涛,石永刚,等.非小细胞肺癌脑转移立体定向X刀放疗联合全脑照射100例[J].郑州大学学报(医学版),2009,(04):877.
[3]王珍珍),周云)#,王文玉),等.非小细胞肺癌组织中Survivin蛋白的表达[J].郑州大学学报(医学版),2010,(04):653.
 [J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(05):653.
[4]马望,樊青霞,王留兴#,等.非小细胞肺癌患者化疗前后血清IGF1和IGFBP3水平的变化[J].郑州大学学报(医学版),2010,(04):663.
 [J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(05):663.
[5]葛辰蕾),李醒亚),尚可),等.非小细胞肺癌预后影响因素分析*[J].郑州大学学报(医学版),2011,(02):216.
 GE Chenlei),LI Xingya),SHANG Ke),et al. Analysis of prognostic factors for nonsmall cell lung cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(05):216.
[6]刘瑜,王娜,冯斐斐,等.非小细胞肺癌组织中CD68与cJun蛋白的表达*[J].郑州大学学报(医学版),2011,(06):861.
 LIU Yu,WANG Na,FENG Feifei,et al.Expressions of CD68 and cJun proteins in nonsmall cell lung cancer tissue[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(05):861.
[7]刘萍△,王豪勋.非小细胞肺癌组织中RRM1的表达与含吉西他滨方案耐药的关系[J].郑州大学学报(医学版),2011,(06):876.
 LIU Ping,WANG Haoxun.Relationship between RRM1 expression in non smallcell lung cancer tissue and gemcitabinecontaining regimen resistance[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(05):876.
[8]刘天舟)△,张琳),王庆芳).非小细胞肺癌患者血清CA153、CA242及CYFRA211水平测定[J].郑州大学学报(医学版),2012,(01):113.
 LIU Tianzhou,ZHANG Lin,WANG Qingfang.Determination of CA153,CA242 and CYFRA211 in serum of patients with nonsmall cell lung cancer[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2012,(05):113.
[9]刘少平△,钱文军,茅卫东.恩度对晚期非小细胞肺癌患者血清VEGF和bFGF的影响*[J].郑州大学学报(医学版),2013,(01):144.
[10]孙丽娟△,付群,李宏云,等.EGFR、KRAS、BRAF、PI3K基因突变与非小细胞肺癌靶向药物治疗的关系[J].郑州大学学报(医学版),2013,(01):147.

更新日期/Last Update: 2010-10-28